| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
- | - | - | 0 | - | - | - | 0 | 0 |
OPERATING EXPENSES | ||||||||
General and administrative | ||||||||
6,017 | 6,016 | 4,462 | 3,431 | 7,641 | 9,085 | 0 | 0 | 0 |
Research and development | ||||||||
3,462 | 3,281 | 4,383 | 3,870 | 3,863 | 3,354 | 0 | 0 | 0 |
Waiver of common stock issuable | ||||||||
- | - | - | 0 | - | - | - | - | - |
Total operating expenses | ||||||||
7,937 | 7,756 | 7,303 | 5,759 | 11,504 | 12,440 | 0 | 0 | 0 |
LOSS FROM OPERATIONS | ||||||||
-7,937 | -7,756 | -7,303 | -5,759 | -11,504 | -12,440 | 0 | 0 | 0 |
OTHER INCOME | ||||||||
Interest income | ||||||||
89 | 77 | 0 | 0 | 0 | - | - | - | - |
Total other income | ||||||||
89 | 77 | 0 | 0 | 0 | - | - | - | - |
NET LOSS | ||||||||
-7,847 | -7,678 | -7,240 | -5,712 | -11,494 | -12,440 | 0 | 0 | 0 |
Net loss per common share - basic and diluted | ||||||||
-0.19 | -0.23 | -0.28 | -0.04 | -0.20 | -0.21 | -0.18 | -0.71 | -0.33 |
Weighted average number of common shares outstanding - basic and diluted | ||||||||
10,747 | 10,788 | 10,762 | 10,150 | 9,388 | 8,721 | 8,719 | 8,719 | 8,546 |
COMPREHENSIVE LOSS | ||||||||
NET LOSS | ||||||||
-7,847 | -7,678 | -7,240 | -5,712 | -11,494 | -12,440 | 0 | 0 | 0 |
Other comprehensive loss - loss on foreign currency translation | ||||||||
0 | - | 0 | - | 0 | - | 0 | - | - |
Other comprehensive loss - loss on foreign currency translation | ||||||||
- | - | - | 0 | - | - | - | 0 | 0 |
Total comprehensive loss | ||||||||
-7,882 | -7,693 | -7,303 | -5,748 | -11,535 | -12,465 | 0 | 0 | 0 |